White label – Pompe disease - ClinicalTrials.eu

Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

Recruiting

2 1 1
Investigated Diseases:
- Pneumonia
Investigated Drugs:
- Levofloxacin
- Sodium Chloride
Study on Fludarabine, Melphalan, and ATG for Patients with Blood Cancer Undergoing Reduced Intensity Stem Cell Transplantation

Recruiting

3 1 1 1
Investigated Diseases:
- Allogenic stem cell transplantation
Investigated Drugs:
Study on the Effectiveness of 2LHERP in Reducing Recurrent Cold Sores in Patients with Frequent Outbreaks

Recruiting

3 1 1
Investigated Diseases:
- Herpes simplex
- Oral herpes
Investigated Drugs:
Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

Recruiting

2 1 1 1
Investigated Drugs:
- Apremilast
Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn’s Disease

Recruiting

3 1 1
Investigated Drugs:
- Mirikizumab
+8
Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

Recruiting

3 1 1
Investigated Diseases:
- Post procedural complication
Investigated Drugs:
- Tranexamic Acid
- Sodium Chloride
Study on 7-Day vs. 14-Day Antibiotic Treatment for Kidney Infection in Transplant Patients Using Bromhexine Hydrochloride, Trimethoprim, and Fluoroquinolones

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Recruiting

3 1
Investigated Drugs:
- Carisbamate
+1
Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

Recruiting

3 1 1 1
Investigated Drugs:
- Rituximab
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies